Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New surgical stapler shows promise in lung cancer operations

NCT ID NCT07354854

Disease control Sponsor: Ezisurg Medical Co. Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a new surgical stapler (easyEndo™ Lite) in 30 people undergoing lung cancer surgery. The goal was to see if the device safely cuts and seals lung tissue. Researchers checked for successful sealing, surgery time, blood loss, and complications. The study is complete, but results are not yet widely available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
easyEndo™ Lite Linear Cutting Stapler (device)
What this could lead to
If successful, this could confirm that the stapler is a safe and effective tool for lung surgery, potentially improving surgical outcomes.
What could go wrong
This is a small, completed study with only 30 participants, so results may not apply to all patients. There are standard surgical risks like bleeding or air leaks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Older than 18 years old, male or female; 2. Subjects are scheduled to undergo open or thoracoscopic puimonary surgery with any surgicalprocedure; 3. The surgery is performed using the easyEndotm Lite Linear Cuting Stapler for Single Use andLoading Unites for Single Use for tissue cutting and suturing. Exclusion Criteria: 1. Non-elective surgery; 2. Previous surgical operation on the ipsilateral lung; 3. Pregnant or lactating women; 4. Patients who, in the judgment of the investigator, are unsuitable to participate in the study for other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer (diagnosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer (diagnosis)

Contacts and locations

Locations

  • Jinhua Municipal Central Hospital

    Jinhua, Zhejiang, 321000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.